OasisLMS

The ASNC2026 Meeting OnDemand (MOD) course provides you with top-notch education highlighting how nuclear cardiology is expanding rapidly across amyloidosis, artificial intelligence, hybrid imaging, infection, inflammation, molecular imaging, myocardial blood flow quantification, radiopharmaceuticals, sarcoid, and much more.

The sessions provided shared valuable insights on disease-based tracks, radiopharmaceutical innovations, and new diagnostic techniques that every nuclear cardiology professional needs to know. Earn up to 26 CME credits.

These sessions were recorded during the live / virtual ASNC2026 Annual Scientific Session and Exhibition, September 16-19, and September 26, 2026.

CME Expiration Date: October 1, 2028* 
*CME Credits must be claimed by this date.

This online activity consists of OnDemand lectures recorded from the ASNC2026 sessions. In order to claim CME credits*, you must listen to the recordings and then complete the Evaluation. You can claim credit as you progress through the activity, e.g., watch 2 sessions, claim credit, complete the evaluation, and receive your CME Certificate. If you watch other presentations and claim credit after completing the evaluation, your CME Certificate will denote the additional credits. This course does not carry ABIM Maintenance of Certification (MOC) points.

*CME Expiration Date: October 1, 2028*  

This course is intended for cardiologists, radiologists, nuclear medicine specialists, nuclear technologists, nurses, practice administrators, and other health care professionals with an interest in the field of nuclear cardiology.

At the end of this activity, participants will:

• Demonstrate improved skills in image interpretation and reporting
• Recognize and minimize technical problems and artifacts that may be associated with cardiac imaging
• Identify appropriate use of cardiac imaging techniques based on current guidelines
• Evaluate new imaging technologies, software, and stress techniques
• Identify the role of nuclear and cardiac CT imaging in overall patient care
• Describe the importance of balancing radiation exposure with image quality
• Describe future directions in cardiac PET/CT and SPECT/CT to anticipate training and equipment needs
• Identify the clinical implication of CT coronary angiography cases and recognize its value and limitations in clinical cardiology

This activity will increase learners’ competence in solving technical and clinical issues when treating patients with CVD. Sessions present different approaches to cardiac disease management to how to best improve patient outcomes. These sessions address topics in appropriate use criteria, SPECT best practices, PET best practices, new and emergent cardiac imaging procedures, lab performance and procedures, radiation safety, reporting, and lab performance and the application of appropriate guidelines-based treatments.

To maintain competence and improve performance, imaging professionals must assimilate and integrate knowledge spanning multiple areas, including clinical data, technical aspects of imaging, and appropriate application of imaging (e.g., clinical guidelines and appropriate use criteria). Each of these areas is constantly evolving, particularly as innovative technologies and novel pharmacologic agents are introduced. ASNC2026 is an educational activity designed to help imaging professionals on how to best improve outcomes for their patients with CVD.

Physicians: The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Nuclear Cardiology designates this enduring activity for 26 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.



Physician Assistants: The American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME.

Nurse Practitioners: The American Academy of Nurse Practitioners Certification Board (AANPCP) recognizes attendance at continuing education offerings which provide AMA PRA Category 1 Credits™ for the purpose of recertification.

As an accredited provider of the Accreditation Council for Continuing Medical Education (ACCME), The American Society of Nuclear Cardiology (ASNC) adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. In compliance with these standards, it is ASNC’s policy to ensure balance, independence, objectivity, and scientific merit in all its educational activities through the disclosure of all relationships with ineligible companies and mitigation of conflicts of interest. The financial interest or relationships requiring disclosure are outlined in ASNC’s CME Conflict of Interest Policy. All planners, reviewers, and presenters involved with this activity were required to disclose all financial relationships. The American Society of Nuclear Cardiology has reviewed this activity’s faculty disclosures and mitigated all identified conflicts of interest.

PLANNERS

Program Chairs
Paul Cremer, MD, MS – Chair
Brett W. Sperry, MD, FASNC – Vice Chair
Roxana Campisi, MD, MASNC – International Vice Chair

Program Committee

FACULTY/PLANNER/ABSTRACT PRESENTER DISCLOSURES

The following individuals have stated that they have no financial relationships with any ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing products used by or owned by patients, including computer software/hardware, related to the content of the educational presentation in which they are involved:

 
The following individuals have provided financial relationships with ineligible company whose primary business is producing, marketing, selling, re-selling, or distributing products used by or own patients, including computer software/hardware, related to the content of the educational presentation in which they are involved:

Al-Mallah, Mouaz - Research Grant - Siemens, GE HealthCare; Consultant - Jubilant, Pfizer, Philips, Medtrace, GE HealthCare

Ananthasubramaniam, Karthikeyan - Speakers Bureau - Bristol Meyers Squibb and Bridge Bio (non-branded); Advisory Board - Alnylam, BridgeBio; Research/Grant - Alnylam, Bristol Mysers Squibb, Ionis, Kardigan, Novo Nordisk

Armstrong, Ian - Speaker Honorarium - Siemens Healthineers; Departmental Research Collaborations - Siemens Healthineers

Arumugam, Parthiban - Speaker Support - Blue Earth Diagnostics Ltd, IBA

Avery, Ryan - Honoraria - Siemens Healthineers

Bailly, Matthieu - Consulting Fee - Naogen; Honoraria - GE Healthcare

Benz, Dominik - Advisory Board - Astra Zeneca; Consulting Fee - Astra Zeneca, Pfizer

Boczar, Kevin - Advisory Board: Novo Nordisk; Consulting Fee: Novo Nordisk; Research/Grant or Contractor: MedTrace, Kiniksa Pharmaceuticals, Ventyx Biosciences Inc., CareDx Inc.

Bourque, Jamieson - Consultant - GE Healthcare

Bravo, Paco - Research/Grant or Contractor - NOVA Biomedical; Consulting Fee - Cardiovascular Clinical Sciences, Inc; Advisory Board - Life Molecular Imaging (LMI)

Brown, Jenifer - Consulting Fee - AstraZeneca, Recordati Rare Diseases, Mineralys; Research/Grant or Contractor - AstraZeneca

Case, James - Owner - CVIT; Grant - Bracco, GE, Spectrum Dynamics; Consultant - GE

Chareonthaitawee, Panithaya - Consulting Fee - GE Healthcare, Cardiovascular Clinical Science; Advisory Board - Synektik; Royalty - UpToDate

Clerc, Olivier - Research/Grant or Contractor - Pfizer

deKemp, Robert - Consultant and Royalties - Jubilant Radiopharma; Research Grants - Siemens Molecular Imaging; Consultant - GE Healthcare

Di Carli, Marcelo - Research Grant - Gilead Sciences, GE HealthCare, Sun Pharma, Amgen; Consultant - Medtrace, GE HealthCare, ValoHealth, Bitterroot Bio

Divakaran, Sanjay - Consultant - Foresee Pharmaceuticals

Dorbala, Sharmila - Research/Grant or Contractor - Pfizer, BridgeBio, Attralus, Ionis, Medtrace, AstraZeneca, NIH K24HL157648, NIH R01HL159987, NIH R01HL150342, GE HealthCare; Consulting Fee - Pfizer, BridgeBio, MedTrace

Einstein, Andrew - Research Grants - NHLBI, IAEA, Alexion, Attralus, BridgeBio, Canon, GEHC, Intellia, Ionis, Neovasc, Pfizer, Shockwave Medical; Authorship - Wolters Kluwer Health–UpToDate; Consultant - Artrya

Ferencik, Maros - Advisory Board - Elucid, Cleerly; Consulting Fee - Elucid, Cleerly, HeartFlow, BioMarin; Stock Interest (stocks, stock options or other ownership interest, excluding diversified mutual funds) - Elucid; Research/Grant or Contractor - Cleerly

Gallegos-Kattán, Cesia - Consultant - Pfizer, BridgeBio, AstraZeneca; Advisory Board - Pfizer, BridgeBio, AstraZeneca; Educational Grant - Pfizer

Gropler, Robert - Research/Grant or Contractor - NIH, AHA, EIC, Leducq Foundation; Consulting Fee - AHA

Grossman, Gabriel - Consulting Fee - Pfizer; Speakers' Bureau - Pfizer, Novartis

Hendel, Robert - Speakers' Bureau - Alnylm

Hyafil, Fabien - Consulting Fee - Bracco Imaging, Curium Pharma, Naogen Pharma, Pfizer; Speakers' Bureau - Bracco Imaging, Curium Pharma, GE Healthcare, Naogen Pharma, Pfizer; Stock Interest (stocks, stock options or other ownership interest, excluding diversified mutual funds) - Naogen Pharma

Hyun, Mark - Board of Directors - SNMMI CV Council, IAC NM/PET Division, ASNC

Knuuti, Juhani - Consulting Fee - Synektik SA, GE Healthcare; Speakers' Bureau - Siemens Healthineers

Maddahi, Jamshid - Research Grant (PI) - GE Healthcare; Consultant - GE Healthcare

Malhotra, Saurabh - Speakers Bureau - Pfizer, Alnylam, AstraZeneca, BridgeBio; Advisory Board - Pfizer, Alnylam, BridgeBio

Miller, Edward - Grant - Eidos/BioBridge, Pfizer, Alnylam, Siemens; Consultant - Eidos/BioBridge, Pfizer, Synektik

Miller, Robert - Consultant - Bayer, Alnylam; Research Support - Alberta Innovates

Moura, Filipe - Consultant - Ionis Pharmaceuticals

Packard, René - Consulting Fee - GE Healthcare; Research/Grant - GE Healthcare

Pelletier-Galarneau, Matthieu - Research Support - Jubilant; Speaker - Pfizer

Phillips, Lawrence - Consultant (Member, Clinical Event Adjudication) - Norvo Nordisk; Consultant (Member, Clinical Event Adjudication) - Eli Lily

Ruberg, Frederick - Independent Contractor, Research - Attralus/Cardiovascular Clinical Science; Consultant Advisory Board - eMyosound; Research Grant - Pfizer, BridgeBio, Anumana, TriNetX/AstraZeneca

Sadeghi, Mehran - Salaried Employee or Owner - Boehringer Ingelheim (spouse employer)

Saeed, Ibrahim - Consulting Fee - Guidepoint; Advisory Board - BridgeBio

Sanghani, Rupa - Consultant/Speaker - GE Healthcare, CDL Technologies; Speaker - MedScape

Shah, Nishant - Research Funding; Advisory Board - Pfizer, Inc.; Advisory Board - BridgeBio

Singh, Vasvi - Research Grant - ASNC, Pfizer; Speakers Bureau - Pfizer, AstraZeneca, Alnylam; Consultant - Bridgebio, CCS, WCG, Zoll

Sinusas, Albert - Institutional Grant - Siemens, Jubilant, RevaliaBio; Consultant - Most Cardia LLC, MicroVide, LLC; Material Transfer Agreement - Lantheus

Slomka, Piotr - Intellectual Property Rights - Cedars-Sinai; Royalty - Cedars-Sinai; Consulting Fee - Synektik, Novo Nordisk; Stock Interest (stocks, stock options or other ownership interest, excluding diversified mutual funds) - APQ Health, Nvidia

Smiley, Dia - Advisory Board - Pfizer, BridgeBio, Alnylam, Alexion; Principal Investigator - BridgeBio, Attralus

Soman, Prem - Consulting Fee - Alnylam, Spectrum Dynamics, Eidos, Pfizer

Spadoni Barboza, Joaquim - Advisory Board - Boston Scientific, Shockwave; Consulting Fee - Boston Scientific, Teleflex, Shockwave; Speakers' Bureau - Boston Scientific, Teleflex, Abiomed

Sperry, Brett - Advisory Board - Pfizer, Alnylam, BridgeBio, AstraZeneca; Speakers' Bureau - Pfizer, Alnylam, BridgeBio, AstraZeneca; Consulting Fee - Spectrum Dynamics, Alnylam, AstraZeneca, Pfizer, BridgeBio

Spielvogel, Clemens - Research/Grant or Contractor - FWF Erwin Schroedinger Fellowship; Consulting Fee - Pfizer; Speakers' Bureau - Pfizer, Hermes Medical Solutions, European School of Multimodality Imaging & Therapy (ESMIT), European Society for Radiology (ESR)

Susser, Leah - Research/Grant or Contractor - Jubilant Radiopharma

Tawakol, Ahmed - Consulting Fee - GE Healthcare, Tourmaline, Genentech; Research/Grant or Contractor - Tourmaline, Genentech, Lung Biotechnologies

Weber, Brittany - Consultant and Advisory Board: Novo Nordisk, Horizon, Kiniksa, BMS, Aepha, Esperion

Wechalekar, Ashutosh - Honorarium and Advisory Board - Janssen, GSK, Attralus, Prothena, Pfizer

Zohora, Fatema Tuj - Research Grant: Pfizer

Release Date: October 2, 2026
CME Expiration Date: October 1, 2028*
Course Expiration Date: October 1, 2028

*CME must be claimed by this date.

American Society of Nuclear Cardiology 
10300 Eaton Place, Suite 301
Fairfax, VA  22030 
703-459-2555 | info@asnc.org | www.ASNC.org